NCT06729125View on ClinicalTrials.gov

Transcranial Photobiomodulation With Patients With Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

March 20, 2025

Study Completion Date

April 3, 2025

Conditions
Parkinson Disease
Interventions
DEVICE

transcranial photobiomodulation

Single-session transcranial laser stimulation was administered with a continuous-wave, 1,064-nm laser (Model CG-5000 Laser, Cell Gen Therapeutics LLC, Dallas, TX).

OTHER

exercises training

balance exercises and others

Trial Locations (1)

Unknown

Al Zaytoonah University, Amaan

All Listed Sponsors
lead

Al-Zaytoonah University of Jordan

OTHER

NCT06729125 - Transcranial Photobiomodulation With Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter